Therapeutic Solutions International, Inc. announced the formation of ALS Biologics Inc, a subsidiary company dedicated to accelerating development of the Company's assets related to Amyotrophic Lateral Sclerosis, a progressive motor neuron degenerative disease for which no cure exists. The company was formed based on previous positive observations in patients treated with the Company's ALScell?? (JadiCell??) product under the Right to Try Law.
Therapeutic Solutions International, Inc.
Equities
TSOI
US8833781011
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0006 USD | 0.00% | 0.00% | -40.00% |
1st Jan change | Capi. | |
---|---|---|
-40.00% | 2.64M | |
+12.69% | 129B | |
-9.11% | 10.77B | |
+2.17% | 9.05B | |
+19.83% | 7.38B | |
+22.25% | 4.88B | |
+7.26% | 3.41B | |
-0.70% | 3.07B | |
-5.07% | 2.24B | |
-4.22% | 2.12B |
- Stock Market
- Equities
- TSOI Stock
- News Therapeutic Solutions International, Inc.
- Therapeutic Solutions International, Inc. Announces Formation of ALS Biologics Inc to Commercialize Regenerative Technologies Related to Dreaded Motor Neuron Disease